← Open Payments lookup

SAMER MOGHADDAM: Open Payments

NPI 1275700478 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$583 in 28 payments from 9 companies in 2025. Trend: 2023 $672 · 2024 $1,146 · 2025 $583

Food & beverage: $583
CompanyPaymentsAmount
GlaxoSmithKline, LLC.16$319
GENZYME CORPORATION3$57
Viatris Specialty LLC2$49
Insmed, Inc.2$48
ABIOMED1$32
Merck Sharp & Dohme LLC1$22
ANI Pharmaceuticals, Inc.1$21
Regeneron Healthcare Solutions, Inc.1$19
Phadia US Inc.1$16

Products named: NUCALA, TRELEGY ELLIPTA, DUPIXENT, YUPELRI, Arikayce, WINREVAIR, PURIFIED CORTROPHIN GEL, ImmunoCAP.

Industry payments across CA — which companies pay providers there.